Optimizing the Care of Patients With Higher-Risk Myelofibrosis

Learning Objectives:

• Describe key pathophysiologic mechanisms and diagnostic criteria for myelofibrosis based on clinical, morphologic, and molecular findings
• Apply available criteria to ensure accurate risk assessment of patients with myelofibrosis
• Assess the benefits and risks of current treatment options for patients with higher-risk myelofibrosis
• Assess patient preferences and goals to support optimal treatment selection and care planning for patients with higher-risk myelofibrosis
• Apply best practices for side-effect management to preserve quality of life and ensure continued benefit of therapy